SORBS1
Basic information
Region (hg38): 10:95311771-95561414
Previous symbols: [ "SH3D5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SORBS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 86 | 94 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 86 | 8 | 6 |
Variants in SORBS1
This is a list of pathogenic ClinVar variants found in the SORBS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-95315104-C-T | Benign (Jul 23, 2018) | |||
10-95315108-T-C | Benign (Jul 23, 2018) | |||
10-95318368-C-T | not specified | Uncertain significance (Dec 27, 2022) | ||
10-95318370-T-C | not specified | Uncertain significance (Aug 12, 2022) | ||
10-95318371-C-A | not specified | Uncertain significance (Jul 13, 2021) | ||
10-95318371-C-T | not specified | Uncertain significance (Oct 04, 2022) | ||
10-95318384-C-T | Likely benign (May 08, 2018) | |||
10-95322002-C-T | not specified | Uncertain significance (Jul 27, 2022) | ||
10-95336540-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
10-95336576-C-T | not specified | Uncertain significance (Nov 21, 2023) | ||
10-95336577-G-A | not specified | Uncertain significance (Sep 12, 2023) | ||
10-95336610-C-T | not specified | Uncertain significance (Feb 05, 2024) | ||
10-95336628-C-T | not specified | Likely benign (Aug 19, 2021) | ||
10-95336741-G-T | not specified | Uncertain significance (Jun 28, 2023) | ||
10-95336751-C-T | not specified | Uncertain significance (May 31, 2023) | ||
10-95336799-G-A | not specified | Uncertain significance (Aug 08, 2022) | ||
10-95336804-G-A | not specified | Uncertain significance (Jan 19, 2024) | ||
10-95336853-C-T | not specified | Uncertain significance (Apr 20, 2023) | ||
10-95336906-G-A | not specified | Uncertain significance (Oct 06, 2021) | ||
10-95336929-G-C | not specified | Uncertain significance (Sep 06, 2022) | ||
10-95337020-C-G | Malignant tumor of prostate | Uncertain significance (-) | ||
10-95337032-C-T | not specified | Uncertain significance (Apr 07, 2022) | ||
10-95337033-G-A | not specified | Uncertain significance (Aug 16, 2021) | ||
10-95337153-G-C | not specified | Uncertain significance (Jun 02, 2023) | ||
10-95337165-G-A | not specified | Uncertain significance (Dec 17, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SORBS1 | protein_coding | protein_coding | ENST00000371247 | 31 | 249644 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.53e-12 | 1.00 | 125688 | 0 | 60 | 125748 | 0.000239 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.50 | 625 | 740 | 0.845 | 0.0000425 | 8353 |
Missense in Polyphen | 211 | 280.7 | 0.7517 | 3200 | ||
Synonymous | 1.22 | 261 | 287 | 0.909 | 0.0000177 | 2606 |
Loss of Function | 4.44 | 33 | 74.3 | 0.444 | 0.00000408 | 842 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000567 | 0.000565 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.000280 | 0.000277 |
European (Non-Finnish) | 0.000250 | 0.000237 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000198 | 0.000196 |
Other | 0.000338 | 0.000326 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in tyrosine phosphorylation of CBL by linking CBL to the insulin receptor. Required for insulin- stimulated glucose transport. Involved in formation of actin stress fibers and focal adhesions (By similarity). {ECO:0000250|UniProtKB:Q62417}.;
- Pathway
- Adherens junction - Homo sapiens (human);PPAR signaling pathway - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Integrin-mediated Cell Adhesion;PPAR signaling pathway;Insulin Signaling;Smooth Muscle Contraction;Muscle contraction;Insulin Pathway
(Consensus)
Recessive Scores
- pRec
- 0.162
Intolerance Scores
- loftool
- 0.809
- rvis_EVS
- 0.48
- rvis_percentile_EVS
- 79.05
Haploinsufficiency Scores
- pHI
- 0.333
- hipred
- Y
- hipred_score
- 0.599
- ghis
- 0.552
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.511
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sorbs1
- Phenotype
- hematopoietic system phenotype; immune system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- muscle contraction;cell-matrix adhesion;insulin receptor signaling pathway;cellular response to insulin stimulus;stress fiber assembly;positive regulation of glycogen biosynthetic process;positive regulation of glucose import;positive regulation of insulin receptor signaling pathway;positive regulation of lipid biosynthetic process;focal adhesion assembly;positive regulation of protein localization to plasma membrane
- Cellular component
- stress fiber;nucleus;centrosome;cytosol;plasma membrane;insulin receptor complex;cell-cell adherens junction;zonula adherens;cell-substrate adherens junction;focal adhesion;nuclear matrix;membrane raft
- Molecular function
- actin binding;SH3/SH2 adaptor activity;insulin receptor binding;protein binding;cytoskeletal protein binding